Higher Dosage Approval: The FDA approved a new, higher 7.2 mg dose of Wegovy (Wegovy HD), designed to achieve greater, long-term weight reduction.Safety Concerns & Regulations: Reports have linked Wegovy to a potential risk of "eye stroke" (ischemic optic neuropathy)
After those dates, compounding pharmacies can still produce semaglutide under certain circumstances
ADAs 2026 Standards are expanding the relevance of GLP-1-based therapies in diabetes, obesity, and related metabolic care
The Retatrutide 20mg x2 Bundle eliminates this risk by placing both pens in your facility before the study begins
If genetic testing reveals suboptimal GLP1R sensitivity, tirzepatide or dual-action medications may produce superior results
But I think your point also that there was already a change in energy intake immediately is apropos for sure